Immunotherapy of human cancer.
D000276:Adjuvants, Immunologic; D000818:Animals; D000951:Antigens, Neoplasm; D000956:Antigens, Viral; D001500:BCG Vaccine; D001854:Bone Marrow Cells; D016026:Bone Marrow Transplantation; D002822:Choriocarcinoma / Q000628:therapy; D006224:Cricetinae; D005260:Female; D005333:Fetus; D006801:Humans; D006968:Hypersensitivity, Delayed; D007106:Immune Sera; D007111:Immunity, Cellular; D007112:Immunity, Maternally-Acquired; D007167:Immunotherapy / Q000009:adverse effects; D007938:Leukemia / Q000628:therapy; D008264:Macrophages / Q000637:transplantation; D008545:Melanoma / Q000628:therapy; D051379:Mice; D009368:Neoplasm Transplantation; D009369:Neoplasms / Q000628:therapy*; D011247:Pregnancy; D051381:Rats; D014765:Viral Vaccines
D000276:Adjuvants, Immunologic; D000951:Antigens, Neoplasm; D000956:Antigens, Viral; D001500:BCG Vaccine; D007106:Immune Sera; D014765:Viral Vaccines